Tara L Lynchard, CNM, FNP-C | |
208 Columbus St, Hicksville, OH 43526-1250 | |
(419) 542-7718 | |
(419) 542-6544 |
Full Name | Tara L Lynchard |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 208 Columbus St, Hicksville, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881866655 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Tara L Lynchard, CNM, FNP-C 208 Columbus St, Hicksville, OH 43526-1250 Ph: () - | Tara L Lynchard, CNM, FNP-C 208 Columbus St, Hicksville, OH 43526-1250 Ph: (419) 542-7718 |
News Archive
New human and animal studies released today uncover the extensive brain wiring used in communication and provide new insights into how the brain processes and produces language, accents, and sounds. The research also explores the brain abnormalities in people with speech and language problems, such as stuttering, suggesting future treatment avenues. The new findings were presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.
Women who are deficient in vitamin D in the first 26 weeks of their pregnancy may be at risk of developing severe preeclampsia, a potentially life-threatening disorder diagnosed by an increase in blood pressure and protein in the urine, according to research by the University of Pittsburgh Graduate School of Public Health.
Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.
A monitor developed at the University of Strathclyde in Glasgow, Scotland, to help prevent over-exposure to the sun is set to go on the market as part of a new spinout company.
› Verified 3 days ago